基于常规医疗数据研究急性肾损伤的共识定义:范围综述与德尔菲专家意见
该研究通过范围综述发现,利用常规医疗数据研究AKI时对KDIGO定义的应用不一致且描述不充分,174项研究中仅33%报告基线肌酐定义、20%定义肾功能恢复。随后采用改良德尔菲法(55人受邀,第一轮35人、第二轮25人参与,共识阈值75%)仅就基线肌酐定义、排除患者及持续性CKD/未恢复定义达成部分共识,专家呼吁扩展KDIGO指南以标准化AKI定义。
要点
- 常规医疗数据研究中AKI定义应用不一致,基线肌酐和恢复定义报告率低(33%和20%)。
- 德尔菲专家仅就基线肌酐、排除患者及持续性CKD/未恢复定义达成部分共识。
- 建议扩展KDIGO指南,纳入基于常规数据的标准化AKI定义。
核心结论
- 当前利用常规收集数据定义AKI的方法不一致且文献描述不充分。
- 专家未能就AKI定义及其后遗症描述的许多方面达成共识。
- 建议扩展KDIGO指南,纳入使用常规收集数据时AKI的标准化定义。
研究设计与样本
- 范围综述检索Medline和EMBASE,纳入使用医疗数据以KDIGO肌酐定义研究AKI的研究。
- 范围综述共纳入174项符合标准的研究。
- 国际专家小组参与改良德尔菲过程,通过互联网问卷进行2轮调查,预设共识阈值为75%一致。
- 55名受邀者中,第一轮35人参与,第二轮25人参与。
主要发现
- 范围综述发现KDIGO定义应用不一致,应用方法描述不佳。
- 58篇(33%)论文未提供基线肌酐值确定方式的定义。
- 仅34篇(20%)定义了肾功能恢复。
- 德尔菲过程在基线肌酐定义、应排除哪些患者以及如何定义持续性CKD或AKI未恢复等方面达成部分共识。
关键数值与推荐
- 德尔菲共识预设阈值为75%一致。
- 范围综述中58篇(33%)未提供基线肌酐确定定义,34篇(20%)定义肾功能恢复。
临床怎么用
- 肾内科医生在利用常规医疗数据研究AKI时,应注意基线肌酐和恢复定义的不一致性。
- 临床研究中参考德尔菲部分共识领域(基线肌酐、排除患者、持续性CKD/未恢复)以改进AKI定义。
局限性
- 德尔菲专家组成员主要来自英国、美国和加拿大。
- 第一轮部分问题的应答率较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: The KDIGO (Kidney Disease: Improving Global Outcomes) definition of acute kidney injury (AKI) is frequently used in studies to examine the epidemiology of AKI. This definition is variably interpreted and applied to routinely collected health care data. The aim of this study was to examine this variation and to achieve consensus in how AKI should be defined for research using routinely collected health care data. SOURCES OF EVIDENCE AND STUDY DESIGN: Scoping review via searching Medline and EMBASE for studies using health care data to examine AKI by using the KDIGO creatinine-based definition. An international panel of experts formed to participate in a modified Delphi process to attempt to generate consensus about how AKI should be defined when using routinely collected laboratory data. CHARTING METHODS AND ANALYTICAL APPROACH: The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) extension for scoping reviews was followed. For the Delphi process, 2 rounds of questions were distributed via internet-based questionnaires to all participants with a prespecified cutoff of 75% agreement used to define consensus. RESULTS: The scoping review found 174 studies that met the inclusion criteria. The KDIGO definition was inconsistently applied, and the methods for application were poorly described. We found 58 (33%) of papers did not provide a definition of how the baseline creatinine value was determined, and only 34 (20%) defined recovery of kidney function. Of 55 invitees to the Delphi process, 35 respondents participated in round 1, and 25 participated in round 2. Some consensus was achieved in areas related to how to define the baseline creatinine value, which patients should be excluded from analysis of routinely collected laboratory data, and how persistent chronic kidney disease or nonrecovery of AKI should be defined. LIMITATIONS: The Delphi panel members predominantly came from the United Kingdom, the United States, and Canada, and there were low response rates for some questions in round 1. CONCLUSIONS: The current methods for defining AKI using routinely collected data are inconsistent and poorly described in the available literature. Experts could not achieve consensus for many aspects of defining AKI and describing its sequelae. The KDIGO guidelines should be extended to include a standardized definition for how AKI should be defined when using routinely collected data.
引用
- Guthrie G, Guthrie B, Walker H, et al. Developing an AKI Consensus Definition for Database Research: Findings From a Scoping Review and Expert Opinion Using a Delphi Process. Am J Kidney Dis. 2021. PMID: 34298142. doi:10.1053/j.ajkd.2021.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。